Get in touch

SFDA approves Tiefenbacher facilities

Tiefenbacher Group - Aerial view of Riyadh city skyline at sunset with modern skyscrapers, including the Kingdom Centre, under a dramatic sky. "Tiefenbacher Group" logo is at the top left, representing pharmaceutical healthcare solutions.

Tiefenbacher: Own manufacturing and laboratory facilities successfully registered by the Saudi Food and Drug Authority (SFDA) for GCC regionThe SFDA approves Tiefenbacher facilities! We are happy to announce that our manufacturing and laboratory facilities for oral solids at AET Laboratories in Hyderabad (India) have been successfully registered by the Saudi Food and Drug Authority (SFDA). […]

Tiefenbacher Group is committed to becoming climate neutral

Tiefenbacher Group - Solar panels and wind turbines in a green field with mountains in the background under a blue sky, highlighting TIEFENBACHER GROUP’s commitment to patient-centric drug development. The TIEFENBACHER GROUP logo appears in the top left corner.

Tiefenbacher Group is committed to becoming climate neutral by the end of 2025 – sustainability contribution to make life better for people and planetWe are pleased to share that TIEFENBACHER GROUP is committed to becoming climate neutral by the end of 2025*. As a value-driven healthcare company, dedicated to improving the life of patients worldwide, […]

Tiefenbacher Group: Renovating Headquarters in Hamburg

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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 Group: Renovating Headquarters in Hamburg /Germany – an agile, open-plan work spaceTiefenbacher Group is renovating the Headquarters in Hamburg for flexible working while maintaining the importance of the office as a place for collaboration and personal interaction. Did you know that Tiefenbacher Group is currently renovating its headquarters in Hamburg, Germany as a response […]

Tiefenbacher Group at DCAT week 2023

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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 Group at DCAT 2023 – Thanks for meeting us in New York City!It has been four very successful and inspiring days for TIEFENBACHER GROUP in New York City. We were delighted to be able to participate in such an important event and look forward to expand these exciting meetings and interesting conversations that we […]

Tiefenbacher Generic Launch: antihistamine Bilastine

Tiefenbacher Group - A smiling young man in a blue shirt lies on his back in green grass with his hands behind his head, reflecting the patient-centric drug development focus of Tiefenbacher Pharmaceuticals. The company’s logo appears in the top left corner.

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is starting, we at Tiefenbacher Pharmaceuticals are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany. […]

Tiefenbacher registered by United Arab Emirates Ministry of Health

Tiefenbacher Group - A panoramic cityscape of Dubai with the Burj Khalifa towering over other skyscrapers at sunset, highlighting the Tiefenbacher Group—a family-owned pharmaceutical company known for API distribution—in the upper left corner.

Tiefenbacher Group manufacturing sites have been successfully registered by the United Arab Emirates Ministry of HealthThe Tiefenbacher Group is very excited to announce that our two manufacturing sites at AET Laboratories in Hyderabad (India) and at Delorbis in Lefkosia (Cyprus) have been successfully registered by the United Arab Emirates Ministry of Health! The United Arab […]

Tiefenbacher marks World Cancer Day 2023

Tiefenbacher Group - Four adults stand outdoors holding hands and smiling in a bright, cheerful setting with green trees. The "Tiefenbacher Pharmaceuticals" logo appears in the upper left, highlighting expertise in pharmaceutical healthcare solutions.

TIEFENBACHER marks ‘World Cancer Day 2023’ to increase awareness prevention throughout media togetherTIEFENBACHER joined to harness the power of social media to raise awareness on cancer early detection and prevention. Furthermore we support cancer survivors and build cancer care capacity for people. These efforts are also a contribution to reduce the global burden of cancer. […]

Tiefenbacher Group wishes a happy Chinese New Year 2023!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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 at Tiefenbacher Group appreciate the diversity of our colleagues very much and are happy to celebrate their local traditions together. This year, on the 22nd of January, people around the world celebrate the Chinese New Year with carnival events, family gatherings, parades, traditional food, fireworks and other festivities. In the culture of our Chinese […]

Tiefenbacher Group wishes a healthy New Year 2023

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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 all over the world, we wish you a happy and healthy New Year 2023!Tiefenbacher Group wishes a everyone a healthy New Year. We hope the year 2023 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the […]

Tiefenbacher Pharmaceuticals New Market Launch: Apremilast (Psoriasis)

Tiefenbacher Group - A smiling woman in a green top and backpack stands with arms outstretched before lush mountains and fields. The logo and text "Tiefenbacher Pharmaceuticals" highlights their pharmaceutical healthcare solutions in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the psoriasis medication Apremilast in CanadaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are excited to share that we have successfully prepared the launch of the generic version of Apremilast […]

Tiefenbacher Pharmaceuticals New Market Launch: Abiraterone for prostate cancer

Tiefenbacher Group - An older man with gray hair smiles while sitting on a couch, wearing a light gray shirt. The logo and name "AET Tiefenbacher Pharmaceuticals," a family-owned pharmaceutical company, is visible in the upper right corner.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launces generic version of the prostate cancer medicines Abiraterone and the value-added product Abiraterone/PrednisoloneWe at Tiefenbacher Pharmaceuticals aim to improve peoples´ lives around the world by making medicines better affordable, better available, and better than before! That´s why we are excited to share that we have successfully prepared the […]

Thanks for visiting us at CPhI 2022 in Frankfurt!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

Tiefenbacher Group: Three Successful Days at CPhI 2023 – Thank you for visiting us in Barcelona!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CPHI 2022, the world`s leading pharma event, has just come to an end. It was wonderful to meet our valued customers and partners in person again. Our experts enjoyed three very successful days full of exciting meetings and inspiring discussions. It […]

TIEFENBACHER GROUP opens new manufacturing site in Cyprus

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

TIEFENBACHER GROUP opens new manufacturing site in Cyprus for drug production of high-quality pharmaceuticals – we continuously expand in novel technologies and capabilities to improve quality and boost 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Did you know that TIEFENBACHER GROUP heavily invests in its in-house production capacities for high-quality pharmaceuticals? We continuously expand in novel technologies and capabilities to improve quality […]

TIEFENBACHER GROUP and OnDosis launch the innovative healthcare brand OYSTA®

Tiefenbacher Group - OYSTA logo beside a medical device showing "10 mg" and a smartphone displaying the OYSTA app for mood tracking, dosage management, and health logs—highlighting patient-centric drug development in pharmaceutical healthcare solutions.

TIEFENBACHER GROUP and OnDosis are thrilled to announce the launch of OYSTA®. The new healthcare brand represents the cooperation initiated in September 2020, including the co-development portfolio of innovative products in five indications. OYSTA® aims to revolutionize the way how patients take their medicines by combining pharmaceuticals with e-health technology to enable intuitive, precise, and […]

Tiefenbacher Pharmaceuticals New Market Launch: Apixaban anticoagulant

Tiefenbacher Group - An older man with gray hair, wearing a yellow long-sleeve shirt and backpack, walks in a lush riverside landscape. In the corner, the logo and text read "AET TIEFENBACHER PHARMACEUTICALS," a family-owned pharmaceutical company.

New Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the anticoagulant medicine Apixaban in CanadaWe at Tiefenbacher Pharmaceuticals are driven by enabling people around the world a better access to more affordable high-quality medicines. That´s why we are happy to share that we have successfully prepared the launch of the generic version of Apixaban for […]

Meet TIEFENBACHER GROUP at CPhI 2022 in Frankfurt /Germany

Tiefenbacher Group - Exhibition hall at CPHI 2022 in Frankfurt, featuring the Tiefenbacher Group booth—a family-owned pharmaceutical company specializing in finished dosage forms and API distribution. Bright lighting and displays create a lively atmosphere.

Meet TIEFENBACHER GROUP at CPhI in Frankfurt from 1-3 Nov and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before!We are very excited to meet our valued customers and partners once again on CPhI 2022, the world´s leading pharma industry event!  Explore our new booth representing Tiefenbacher Group as […]

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!

Tiefenbacher Group - A young child dressed as a doctor smiles and lifts glasses. Text reads: “Looking forward to see you at BePharma | B2B Pharmaceutical Networking, October 10–12, 2022, Mexico City. Pioneering Healthcare. Tiefenbacher Group, a family-owned pharmaceutical company.”.

Meet TIEFENBACHER GROUP at BePharma in Mexico City 2022 from October 10-12!Reach out to AET – Tiefenbacher Group at BePharma the most important Pharma B2B Event in Latin America from October 10-12!  Discover our latest product portfolio in Mexico City and find out how we strive to make pharmaceuticals more affordable, more available, and better than […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher: Employee benefits and climate reduction goals

Tiefenbacher Group - A man holding a coffee cup and a woman with a tablet walk together outdoors, smiling at each other, as she walks a bicycle. The TIEFENBACHER GROUP logo in the top right highlights this family-owned pharmaceutical company specializing in finished dosage forms.

Environmentally friendly and health-promoting: TIEFENBACHER GROUP offers bike leasing to employeesEmployees benefits while reducing our impact on the environment with climate reduction goals – we take action on many fronts.As a healthcare company dedicated to improving people’s lives, TIEFENBACHER has a strong belief in the Duty of Care we have for our employees. We take […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

Tiefenbacher Pharmaceuticals New Market Launch: Teriflunomide

Tiefenbacher Group - A smiling woman in a blue rain jacket takes a selfie outdoors by a rocky river, holding her hood with one hand. Trees and misty mountains are in the background. The Tiefenbacher Pharmaceuticals logo highlights patient-centric drug development.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE MULTIPLE SCLEROSIS MEDICINE TERIFLUNOMIDE IN CANADAWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines better affordable and better available for patients around the world. That´s why we are happy to share that we have successfully prepared the launch of the generic version […]

TIEFENBACHER GROUP OPENS NEW SITE FOR HIGHLY POTENT DRUGS IN INDIA

Tiefenbacher Group - A collage showing groups of people smiling, a modern building with the AETI logo, and a hallway lined with scientific equipment highlights pharmaceutical healthcare solutions. The bottom right corner features the TIEFENBACHER GROUP logo.

TIEFENBACHER GROUP opens new site for highly potent drugs in India – we continuously expand in novel technologies and capabilities to improve quality and boost productivity of better healthcareTiefenbacher Group is excited to announce the ceremonious opening of our new highly potent drug laboratory in Hyderabad, India. The completion of the new building is the […]

WORLD HEALTH DAY @ TIEFENBACHER GROUP

Tiefenbacher Group - A diverse group of five older adults stand outdoors in a park, laughing and smiling together. The Tiefenbacher Group logo is displayed in the top left corner, reflecting their commitment to innovative pharmaceutical healthcare solutions.

World Health Day is on the 7th of April each year – this day marks the anniversary of the World Health Organization which was founded in 1948.Today we celebrate World Health Day. This Day marks the anniversay of the World Health Organization (WHO). In times of a global pandemic and a cruel war in Europe, […]

TIEFENBACHER AT DCAT 2022 IN NEW YORK CITY! – Thanks for Meeting us

Tiefenbacher Group - Blue "DCAT" logo in bold, uppercase letters with a registered trademark symbol in the upper right corner and a horizontal blue line beneath the letters, reflecting excellence in generic medicines manufacturing for finished dosage forms.

TIEFENBACHER GROUP AT DCAT 2022 – THANKS FOR MEETING US IN NEW YORK CITY!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 of the world´s most important pharma events – DCAT-Week in New York City – has just come to an end. It was four very successful and inspiring days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations to our existing and […]

Tiefenbacher Pharmaceuticals New Market Launch: Lacosamide

Tiefenbacher Group - A smiling man gives a piggyback ride to a woman by the sea, both looking happy. The TIEFENBACHER PHARMACEUTICALS logo appears in the top left corner, representing family-owned pharmaceutical company values. The background shows water, grass, and a cloudy sky.

NEW MARKET LAUNCH: TIEFENBACHER PHARMACEUTICALS SUCCESSFULLY LAUNCHES FIRST GENERIC VERSION OF THE EPILEPSY MEDICINE LACOSAMIDE IN AUSTRALIAWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their income level or nationality. That´s why we are happy to share that we have […]

TIEFENBACHER GROUP stands with UKRAINE

Tiefenbacher Group - A modern riverside building at dusk with city lights in the background, overlaid with a transparent blue and yellow filter resembling the Ukrainian flag, symbolizing innovative pharmaceutical healthcare solutions.

Peace and freedom for Ukraine: We, a healthcare company in Europe, stand in solidarity with the people in UkraineTo us at Tiefenbacher Group, it is unbearable to witness what is happening in Ukraine. We condemn the Russian state´s invasion as a brutal act of war against a neighbouring sovereign country. Our thoughts are with everyone […]

MEET TIEFENBACHER GROUP DURING DCAT WEEK IN NEW YORK CITY 2022

Tiefenbacher Group - A young boy dressed as a doctor adjusts his glasses and smiles. Text reads: "Looking forward to see you during DCAT Week, March 20-24th, 2022, New York City. Pioneering patient-centric drug development. Tiefenbacher Group.

Meet TIEFENBACHER GROUP during DCAT week in New York City 2022 from 21-24th march!Reach out to TIEFENBACHER GROUP at DCAT in New York City from 21-24th March and discover our latest ideas to make pharmaceuticals more affordable, more available, and better than before! Contact us to schedule a meeting via info@aet.eu. For information about our […]

TIEFENBACHER GROUP WISHES A HAPPY AND HEALTHY NEW YEAR 2022 FROM ALL OVER THE WORLD!

Tiefenbacher Group - A new school building in India features animal murals, a decorated pillar, and a Telugu sign above the entrance. A blue banner reads "New School Building in India." The TIEFENBACHER GROUP logo, representing a family-owned pharmaceutical company, is in the corner.

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We at TIEFENBACHER GROUP wish you a happy and healthy new year 2022 from all over the world! Please watch the short video for our new year greetings from our colleagues from our three main locations in Hamburg (Germany), Hyderabad (India) and Lefkosia (Cyprus). For information about our product portfolio and innovative health care solutions […]

TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Tiefenbacher Group - A collage showcases Tiefenbacher Group facilities, highlighting modern glass-fronted offices, industrial buildings, manufacturing equipment, and the Tiefenbacher Group logo, reflecting their commitment to patient-centric drug development and pharmaceutical healthcare solutions.

Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its own manufacturing facilities to secure an efficient and reliable supply of our high-quality pharmaceuticals for patients around the world? As fully integrated pharmaceutical company, we offer […]

TIEFENBACHER GROUP at CPhI 2021 in Milano – thank you for visiting us!

Tiefenbacher Group - A black play button icon, symbolizing API distribution, is centered on a plain white background.

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Tiefenbacher Group: Three Successful Days at CPHI 2021 in Milano – Thank you for visiting usWith over 1,300 exhibitors and more than 20,000 attendees the world`s leading pharma eventt CPHI has just come to an end. It was three very successful days for TIEFENBACHER GROUP presenting our latest product portfolio and innovations at Fiera Milano. […]

TIEFENBACHER GROUP: New school building in India

Tiefenbacher Group - A new school building in India features animal murals, a decorated pillar, and a Telugu sign above the entrance. A blue banner reads "New School Building in India." The TIEFENBACHER GROUP logo, representing a family-owned pharmaceutical company, is in the corner.

At TIEFENBACHER GROUP giving back to society is important to us: New school building in IndiaJTNDZGl2JTIwc3R5bGUlM0QlMjJwYWRkaW5nJTNBNTYuMjUlMjUlMjAwJTIwMCUyMDAlM0Jwb3NpdGlvbiUzQXJlbGF0aXZlJTNCJTIyJTNFJTNDaWZyYW1lJTIwc3JjJTNEJTIyaHR0cHMlM0ElMkYlMkZwbGF5ZXIudmltZW8uY29tJTJGdmlkZW8lMkY5Mzg2MDExMzAlM0ZiYWRnZSUzRDAlMjZhbXAlM0JhdXRvcGF1c2UlM0QwJTI2YW1wJTNCcGxheWVyX2lkJTNEMCUyNmFtcCUzQmFwcF9pZCUzRDU4NDc5JTIyJTIwZnJhbWVib3JkZXIlM0QlMjIwJTIyJTIwYWxsb3clM0QlMjJhdXRvcGxheSUzQiUyMGZ1bGxzY3JlZW4lM0IlMjBwaWN0dXJlLWluLXBpY3R1cmUlM0IlMjBjbGlwYm9hcmQtd3JpdGUlMjIlMjBzdHlsZSUzRCUyMnBvc2l0aW9uJTNBYWJzb2x1dGUlM0J0b3AlM0EwJTNCbGVmdCUzQTAlM0J3aWR0aCUzQTEwMCUyNSUzQmhlaWdodCUzQTEwMCUyNSUzQiUyMiUyMHRpdGxlJTNEJTIyVElFRkVOQkFDSEVSJTIwR1JPVVBfc2Nob29sJTIwb3BlbmluZyUyMGluJTIwSW5kaWElMjIlM0UlM0MlMkZpZnJhbWUlM0UlM0MlMkZkaXYlM0UlM0NzY3JpcHQlMjBzcmMlM0QlMjJodHRwcyUzQSUyRiUyRnBsYXllci52aW1lby5jb20lMkZhcGklMkZwbGF5ZXIuanMlMjIlM0UlM0MlMkZzY3JpcHQlM0U=As a value-driven healthcare company, dedicated to improve the life of patients worldwide, we believe that it´s our responsibility to care about the environment and society – especially in the countries in which we operate. That’s why we are happy […]

TIEFENBACHER GROUP at CPhI in Milan 2021

Tiefenbacher Group - A modern exhibition booth for TIEFENBACHER GROUP, a family-owned pharmaceutical company, features a bold blue design, illuminated logo, reception counter, and several people interacting inside a convention or trade show setting.

Reach out to the TIEFENBACHER GROUP at CPHI in Milan 2021 and discover our latest innovations to make pharmaceuticals more affordable, more available, and better than before.“Nothing can replace meeting each other in person!” says Oliver Schrader, Managing Director of Tiefenbacher Group. After nearly two years of mainly digital work, we are very excited to […]

Tiefenbacher Pharmaceuticals: Launch of first generic version of the antihistamine Bilastine

Tiefenbacher Group - A smiling woman with long hair stands in a field of yellow flowers under a clear sky. The Tiefenbacher Pharmaceuticals logo in the top left highlights their dedication to patient-centric drug development and innovative pharmaceutical healthcare solutions.

New market launch: TIEFENBACHER PHARMACEUTICALS successfully launches first generic version of the antihistamine BilastineWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable for all patients irrespective of their income level or nationality. That´s why we are excited to share that we have successfully launched the first generic version of Bilastine (20 […]

New agreement expands collaboration between OnDosis and TIEFENBACHER GROUP

Tiefenbacher Group - Two white and teal handheld medical devices with digital displays showing “10 mg,” next to the Tiefenbacher Group and Ondosis logos, highlight advanced pharmaceutical healthcare solutions for finished dosage forms on a white background.

Innovative Healthcare Pharmaceuticals with e-health technology in the ADHD field, rare diseases, and transplantation medicineSwedish Life science company OnDosis and German B2B pharmaceutical company TIEFENBACHER GROUP initiate four new innovative development projects targeting ADHD, rare diseases, and transplantation medicine. The idea is to improve the health and everyday lives of millions of patients by giving […]

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole against Black Fungus (Mucormycosis)

Tiefenbacher Group - A scientist wearing safety goggles and a lab coat closely observes equipment in a laboratory focused on patient-centric drug development, surrounded by scientific instruments and glassware.

TIEFENBACHER GROUP supports Post COVID-19 with Posaconazole tablets against Black Fungus (Mucormycosis) in IndiaBlack Fungus (Mucormycosis) is dramatically spreading in India connected to the extensive 2nd COVID-19 wave. The highly life-threatening disease usually occurs as a rare disease in immunocompromised patients. However, many patients who have survived their COVID-19 infection with the help of external […]

TIEFENBACHER GROUP announces global launch of TIEFENBACHER MEDICAL DEVICES

Tiefenbacher Group - A young girl wearing glasses and a white lab coat smiles and points upward, standing next to the text "Tiefenbacher Medical Devices," representing innovative pharmaceutical healthcare solutions on a light background.

Innovation healthcare by combining established drug-based medicines with medical devices and digital healthAfter more than five years in operation, TIEFENBACHER GROUP transfer its medical device business into a new stand-alone company: TIEFENBACHER MEDICAL DEVICES. The launch follows TIEFENBACHER GROUP´s strategy to offer better patient therapies by combining established drug-based medicines with medical devices and digital […]

TIEFENBACHER API + INGREDIENTS: FIRST API BASED ON GREEN CHEMISTRY

Tiefenbacher Group - Hands holding soil with a small green seedling, surrounded by digital chemical formulas and hexagons, with sunlight shining in a blurred green background, symbolizing science and growth in pharmaceutical healthcare solutions.

TIEFENBACHER API + INGREDIENTS starts to offer the first API based on green chemistryWe at TIEFENBACHER API + INGREDIENTS are committed to drive greem chemistry in the pharmaceutical raw material industry. Enviero Progesterone is an Active Pharmaceutical Ingredient (API) and the first molecule from TIEFENBACHER API + INGREDIENTS’ green-chemistry program by providing the latest in lower environmental […]

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mgfilm-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. Teriflunomide […]

AET Pharma US Inc., Part of Tiefenbacher, approval of Abbreviated New Drug Application (ANDA) for Posaconazole

Tiefenbacher Group - A large group of people, including men and women in formal and colorful traditional attire, stand on a grassy lawn with a modern glass building behind them, reflecting the unity of a family-owned pharmaceutical company dedicated to patient-centric drug development.

AET Pharma US Inc. announces successful approval of Abbreviated New Drug Application (ANDA) for PosaconazoleOn 1st February 2021, AET Pharma US Inc, part of TIEFENBACHER GROUP, received FDA approval of the Abbreviated New Drug Application (ANDA) for Posaconazole in 100 mg Delayed-Release Tablets. This is another milestone for TIEFENBACHER GROUP in further strengthening its product […]

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for the generic of Rivaroxaban 2.5 mg, 10 mg, 15 mg and 20 mg film-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower […]

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group - A man in a dark suit and glasses sits on a chair by a large window overlooking modern office buildings and a waterfront. He is smiling, has short, light hair, and projects the professionalism of a family-owned pharmaceutical company.

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before”We are very excited to launch the new Tiefenbacher Group website. It represents the fundamental changes which we have started in the recent years. We are on the move to drive important efficiencies in our supply chain and become a […]

Tiefenbacher Group and OnDosis enter a partnership for medicines and digital health

Tiefenbacher Group - Logos of Tiefenbacher Group (blue dots and text) and Ondosis (green and maroon text with a capsule icon) on a white background, representing leaders in patient-centric drug development and pharmaceutical healthcare solutions.

Tiefenbacher Group and OnDosis today announced the signing of an extensive co-development agreement for multiple products in the upcoming years. This collaboration strengthens both companies’ commitment to further develop and commercialize innovative products within individualized treatments and digital health, combining traditional drug-based medicines with digital therapeutics and intelligent dosing. TIEFENBACHER GROUP and OnDosis enter a […]

TIEFENBACHER GROUP SUMMER EVENT 2023

Tiefenbacher Group - A group of about 20 people poses and smiles outdoors under a rainbow decoration, with trees and a building in the background. The blue border features the "Tiefenbacher Group" logo, highlighting their focus on patient-centric drug development.

For our Tiefenbacher Group Social Day we have given our employees in #hamburg time off so that they can get socially involved in an institution in the Hanseatic city. We want to promote the common good in our beloved city and therefore supported the Tierpark Hagenbeck (zoo), the Sternbrücke Children’s Hospice, the Stiftung Das Rauhe Haus (child and youth welfare), the alsterdorf […]

Get in touch